microRNA-125b-1-3p mediates autophagy via the RRAGD/mTOR/ULK1 signaling pathway and mitigates atherosclerosis progression
Cellular Signalling · 2024-06 · 118 · 111136
DOI: 10.1016/j.cellsig.2024.111136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2024-06. Verfasst von Xin Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dongguan Hospital, Guangzhou University of Chinese Medicine, Dongguan, China; Guangzhou University of Chinese Medicine, Guangzhou, China; State Key L…. Hauptthemen laut MEDLINE: Atherosclerosis, MicroRNAs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Atherosclerosis is characterised by lipid accumulation and formation of foam cells in arterial walls. Dysregulated autophagy is a crucial factor in atherosclerosis development. The significance of microRNA (miR)-125b-1-3p in cardiovascular disease is well-established; however, its precise role in regulating autophagy and impact on atherosclerosis in vascular smooth muscle cells (VSMCs) remain unclear. Here, we observed reduced autophagic activity and decreased miR-125b expression during atherosclerosis progression. miR-125b-1-3p overexpression significantly reduced atherosclerotic plaque development in mice; it also led to decreased lipid uptake and deposition in VSMCs, enhanced autophagy, and suppression of smooth muscle cell phenotypic changes in-vitro. An interaction between miR-125b-1-3p and the RRAGD/mTOR/ULK1 pathway was revealed, elucidating its role in promoting autophagy. Therefore, miR-125b-1-3p plays a pivotal role in enhancing autophagic processes, inhibiting foam cell formation in VSMCs and mitigating atherosclerosis progression, partly through RRAGD/mTOR/ULK1 signaling axis modulation. Thus, miR-125b-1-3p is a promising target for preventive and therapeutic strategies for atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dongguan Hospital, Guangzhou University of Chinese Medicine, Dongguan, China; Guangzhou University of Chinese Medicine, Guangzhou, China; State Key Laboratory of Traditional Chinese Medicine Syndromes, The First Affilia…
- Guangzhou University of Chinese Medicine, Guangzhou, China; State Key Laboratory of Traditional Chinese Medicine Syndromes, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China; Ling…
- Dongguan Hospital, Guangzhou University of Chinese Medicine, Dongguan, China; Guangzhou University of Chinese Medicine, Guangzhou, China.
- Dongguan Hospital, Guangzhou University of Chinese Medicine, Dongguan, China; Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: 270177997@qq.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, X., Cao, Y., Guo, Y., Liu, J., Ye, X., Li, H., Zhang, L., Feng, W., Xian, S., Yang, Z., Wang, L., & Wang, T. (2024). microRNA-125b-1-3p mediates autophagy via the RRAGD/mTOR/ULK1 signaling pathway and mitigates atherosclerosis progression. Cellular Signalling, 118, 111136. https://doi.org/10.1016/j.cellsig.2024.111136
Vancouver
Chen X, Cao Y, Guo Y, Liu J, Ye X, Li H, et al. microRNA-125b-1-3p mediates autophagy via the RRAGD/mTOR/ULK1 signaling pathway and mitigates atherosclerosis progression. Cellular Signalling. 2024;118:111136. doi:10.1016/j.cellsig.2024.111136
BibTeX
@article{Chen2024,
author = {Chen, Xin and Cao, Yanhong and Guo, Yining and Liu, Jing and Ye, Xiaohan and Li, Huan and Zhang, Lu and Feng, Wenwei and Xian, Shaoxiang and Yang, Zhongqi and Wang, Lingjun and Wang, Ting},
title = {microRNA-125b-1-3p mediates autophagy via the RRAGD/mTOR/ULK1 signaling pathway and mitigates atherosclerosis progression},
journal = {Cellular Signalling},
year = {2024},
volume = {118},
pages = {111136},
doi = {10.1016/j.cellsig.2024.111136}
}
EUVIMED